Clinical Trials Directory

Trials / Completed

CompletedNCT00722397

TODAY Genetics Study

Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study

Status
Completed
Phase
Study type
Observational
Enrollment
2,654 (actual)
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NIH
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The TODAY study group has prepared a protocol with the primary objective of collecting blood and phenotypic information to be used to explore relationships between candidate genes and type 2 diabetes (T2D), as well as obesity, insulin resistance, and cardiovascular complications of insulin resistance. Participation in the genetics study includes a blood draw for analysis of diabetes type and DNA extraction, as well as collection of basic family and medical history. Appropriate informed consent and assent are obtained from all participants to extract DNA and send blood, genetic material, and medical history to the Central Repository of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH). The data are kept indefinitely by the Central Repository. The NIDDK will issue requests for proposals (RFP) throughout the scientific community for research that may help in the development of new diagnostic tests, new treatments, and new ways to prevent diabetes and other related comorbidities.

Conditions

Timeline

Start date
2008-08-01
Primary completion
2015-02-01
Completion
2015-02-01
First posted
2008-07-25
Last updated
2021-08-04

Locations

25 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00722397. Inclusion in this directory is not an endorsement.

TODAY Genetics Study (NCT00722397) · Clinical Trials Directory